| Product ID |
Product Name |
CAS# |
Purity |
| Y3233530 |
S 32826 |
1103672-43-0 |
95% |
| Y1258736 |
(S)-5-Allyl-2-oxabicyclo[3.3.0]oct-8-ene |
1052236-86-8 |
98% |
| Y3250200 |
2,7-Dibromobenzothiazole |
1188090-10-9 |
95% |
| Y3292414 |
INTERMEDINE |
10285-06-0 |
99% |
| Y3249030 |
N-(2-AMinoethyl)-2,2-diphenylcyclopropanecarboxaMide |
109546-07-8 |
95% |
| Y1313826 |
THIAMINE DISULFIDE NITRATE |
109125-52-2 |
98% |
| Y3227450 |
3'-BroMo-2,2' |
105125-00-6 |
97% |
| Y3260067 |
N-ALPHA-LAUROYL-L-GLUTAMINE |
109570-04-9 |
95% |
| Y3307960 |
Molindone-d8 |
1189805-13-7 |
99% |
| Y1339606 |
6'-Dimethyl-4'-(N-succinimidyloxycarbonyl)phenyl-10-methyl-acridinium-9-carboxylate methosulfate (DMAE-NHS) |
115853-74-2 |
98% |
| Y1254373 |
NEU5GC ALPHA(2-6)GAL BETA MP GLYCOSIDE |
1072896-38-8 |
97% |
| Y1254417 |
4-BroMo-1,1,7,7-tetraethyl-1,2,3,5,6,7-hexahydro-3,3,5,5-tetraMethyl-s-indacene |
1142818-90-3 |
95% |
| Y3251087 |
tylosin B |
11032-98-7 |
95% |
| Y1258738 |
Ethyl 4-(trifluoromethyl)quinoline-2-carboxylate |
1116339-55-9 |
97% |
| Y3313426 |
H2bpzb |
1036248-62-0 |
98% |
| Y3308084 |
OlMesartan-d6 Acid |
1185144-74-4 |
95% |
| Y1232979 |
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl) tetrahydro-2,2-diMethyl-6-phenyl-1,3-dioxolo [4,5-e]dioxaphosphepin |
1187446-93-0 |
98% |
| Y3137299 |
2-Bromo-6,7-dichlorobenzothiazole |
1188247-19-9 |
95% |
| Y3287796 |
Glycerol 1,2-Dichlorohydrin-d5 |
1189730-34-4 |
98% |
| Y3250486 |
Triphenyl phosphate-d15 |
1173020-30-8 |
98%D |
| Y3250150 |
2,4,6-Tris(3,4-dichlorophenyl)boroxin |
1133798-41-0 |
98.0% |
| Y3313306 |
17-alpha,21-dihydroxy-16-alpha-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate |
10106-41-9 |
98% |
| Y1347396 |
ETODOLAC RELATED COMPOUND A (25 MG) ((+/-)-8-ETHYL-1-METHYL-1,3,4,9-TETRAHYDROPYRANO [3,4-B]-INDOLE-1-ACETIC ACID) |
109518-50-5 |
95% |
| Y3251264 |
(Z)-Pitavastatin Calcium Salt |
1159588-21-2 |
95% |
| Y3313941 |
11-Desethyl Irinotecan |
103816-16-6 |
98% |
| Y1263631 |
(4-ethylbenzyl)MethylaMine hydrochloride |
1158321-03-9 |
95% |
| Y3216783 |
N-Desmethyl Clarithromycin |
101666-68-6 |
95% |
| Y3224793 |
2-AMino-5,6-dichloro-3(4H)-quinazoline Acetic Acid HydrobroMide (Anagrelide IMpurity B) |
1194434-39-3 |
95% |
| Y1347254 |
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid |
1132709-15-9 |
95% |
| Y3304800 |
15ß-OH Gibberellin A3 |
105593-18-8 |
95% |
| Y3244404 |
[4-(aminomethyl)cyclohexyl]methanamine |
10029-07-9 |
97% |
| Y3246397 |
4-Amino Propofol Hydrochloride |
100251-91-0 |
95% |
| Y1241827 |
PotassiuM 2-MethoxypyriMidine-5-trifluoroborate |
1111732-99-0 |
98% |
| Y3245640 |
4-(2-Oxiranylmethoxy)-benzeneethanol |
104857-48-9 |
95% |
| Y1246278 |
4-BroMo-2,6-bis[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]-pyridine |
1190936-03-8 |
95% |
| Y3269183 |
TRICLOSAN-D3 |
1020719-98-5 |
98.22% |
| Y3291422 |
1,2-Dehydro-3-oxo RocuroniuM BroMide |
1190105-67-9 |
95% |
| Y1314185 |
Methyl JasMonate (Mixture of isoMers) |
1101843-02-0 |
90% |
| Y3318621 |
FaMotidine Acid IMpurity |
107880-74-0 |
95% |
| Y3311875 |
Gliclazide-d4 |
1185039-30-8 |
98% |
| Y3265707 |
MOEXIPRILAT HYDRATE |
103775-14-0 |
95% |
| Y3288085 |
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE |
102804-82-0 |
95% |
| Y1313824 |
2-BENZYLOXYBENZYL ACETATE |
1073234-31-7 |
95% |
| Y3308546 |
3-Methyl-d3-indole |
111399-60-1 |
98% |
| Y1246280 |
TRANS-2-CARBOMETHOXYCYCLOPENTANE-1-CARBOXYLIC ACID |
111138-44-4 |
95% |
| Y3261319 |
PhosphonoethanolaMine-d4 |
1169692-38-9 |
95% |
| Y1241837 |
2-(Trifluoromethyl)quinoline-4-carbohydrazide |
1185292-58-3 |
97% |
| Y1336634 |
S-METHYL-S-(2-THIAZYL) SULFOXIMINE |
1116339-83-3 |
98% |
| Y3258718 |
N-[4-(ß-Cyclohexylureidoethyl)benzensulfonyl] N'-Cyclohexylurea |
10079-35-3 |
95% |
| D756641 |
7-BroMo-2-chlorobenzothiazole |
1188227-29-3 |
95+% |
| Y1079935 |
2-BroMo-4-fluoronicotinic acid |
1060809-35-9 |
95% |
| Y3261283 |
a,a-DiMethyl-4-[(MethylaMino)Methyl]-2-thiazoleMethanol |
1051463-24-1 |
95% |
| Y1246300 |
2-(4-Chloromethylpiperidin-1-yl)pyrimidine-5-carboxamide |
1116339-77-5 |
97% |
| Y3254416 |
CZBDF |
1092578-51-2 |
98.0%(HPLC) |
| Y3228203 |
Acarbose D-Fructose IMpurity |
1013621-79-8 |
95% |
| Y1241816 |
Fluoxetine-D5 hydrochloride |
1173020-43-3 |
99.6%D |
| Y3312649 |
3-(1,2-Benzisothiazolyl) Ziprasidone(Ziprasidone Impurity E) |
1159977-04-4 |
95% |
| Y3285930 |
CefepiMe interMediate (7-PIME) |
103121-85-3 |
97% |
| Y3318701 |
N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide |
1083100-27-9 |
98% |
| Y3229840 |
2-Chloromethyl-6-bromobenzothiazole |
1188024-80-7 |
95% |
| Y3247965 |
2-Deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-ß-D-glucopyranosyl azide 3,4,6-Triacetate |
102816-24-0 |
98% |
| Y3304767 |
[2S-[2a(R*),3ß]]-N-ForMyl- |
104872-28-8 |
95% |
| D761663 |
2-Bromo-5-methylbenzothiazole |
1093107-11-9 |
95% |
| Y1241899 |
GRANISETRON IMPURITY B |
107007-95-4 |
99%(HPLCGC) |
| Y3261002 |
2-(4-AMino-2-ethoxyphenyl)pthaliMide |
106981-52-6 |
95% |
| Y3262499 |
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
95% |
| Y3306319 |
Ezetimibe-d4 |
1093659-89-2 |
99% |
| Y3253821 |
Benzothiazole, 2-(chloromethyl)-5-fluoro- (9CI) |
110704-60-4 |
95% |
| Y3258609 |
Superstable Pd(0) catalyst |
1130784-80-3 |
95% |
| Y1241818 |
Rivaroxaban-d4 |
1132681-38-9 |
98% |
| D770305 |
2-Methoxy-1-(1-methyl-1H-pyrazol-5-yl)ethanone |
1177283-64-5 |
95% |
| D964694 |
(3aR,8aR)-(-)-4,4,8,8-Tetrakis (3,5-diMethylphenyl)tetrahydro-2,2-diMethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin |
1019840-96-0 |
95% |
| Y1241819 |
Meso-Tetra(4-tert-butylphenyl) Porphine |
110452-48-7 |
95% |
| Y3233296 |
N-((1-(2-(tert-ButylaMino)-2-oxoethyl)piperidin-4-yl)Methyl)-3-chloro-5-fluorobenzaMide |
1199236-64-0 |
98%(HPLC) |
| Y1241829 |
7-BroMo-3-(trifluoroMethyl)-[1,2,4]triazolo[4,3-a]pyridine |
1021923-54-5 |
98% |
| Y1337486 |
2-(Dicyclohexylphosphino)-N,N-bis(1-methylethyl)-1H-indole-1-carboxamide |
1067175-36-3 |
97% |
| Y3246798 |
6,7-Dichloro-2(3H)-benzothiazolone |
1188247-44-0 |
95% |
| Y3224925 |
Benzothiazole, 5-chloro-2-(chloromethyl)- (9CI) |
110704-19-3 |
98% |
| Y3235085 |
2-Chloromethyl-4-bromobenzothiazole |
1188168-47-9 |
95% |
| Y1233003 |
2-(3-Methoxy-phenoxy)-acetamidine hydrochloride |
114986-37-7 |
95% |
| Y3298002 |
3-METHYL-D3-ADENINE |
110953-39-4 |
99% |
| Y3232208 |
Tri-n-hexylphosphine oxide/tri-n-octylphosphine oxide |
100786-00-3 |
92% |
| Y3240043 |
4-Aminobiphenyl -D-Glucuronide Sodium Salt |
116490-30-3 |
95% |
| Y3232262 |
(11ß,16a)-21-(Acetyloxy)-9-chloro-11-hydroxy-16,17-[(1-Methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione |
10392-75-3 |
97% |
| Y3232505 |
5-chloro-6-Methoxypyridin-3-ol |
1196157-30-8 |
95% |
| Y3244939 |
3-FLUORO-2-METHOXYBENZOYL CHLORIDE |
106428-06-2 |
95% |
| Y3244864 |
2-FLUORO-4-METHYL-DL-PHENYLGLYCINE |
1039118-67-6 |
95% |
| Y3249935 |
2,3,4-TRIFLUORO-DL-PHENYLGLYCINE |
1039627-62-7 |
95% |
| Y3245237 |
4-FLUORO-3-(TRIFLUOROMETHOXY)PHENYLACETONITRILE |
1020718-23-3 |
95% |
| D958366 |
3-CHLORO-4-(TRIFLUOROMETHYL)BENZONITRILE |
1092460-79-1 |
97% |
| Y1237249 |
2-(4-PHENYL-PYRIMIDIN-2-YL)-ETHYLAMINE DIHYDROCHLORIDE |
1187930-50-2 |
95% |
| Y1314218 |
adenosine5’-diphosphate,monosodiumsaltdihydrate |
1172-42-5 |
98% |
| Y3312561 |
Histatin 5 |
115966-68-2 |
98% |
| Y1237350 |
IFLAB-BB F1670-0186 |
1095080-29-7 |
95% |
| Y3222107 |
1-(4-FLUORO-PHENYL)-1,2,3,4-TETRAHYDRO-PYRROLO[1,2-A]PYRAZINE |
112767-38-1 |
95% |
| Y3227066 |
IFLAB-BB F0348-2809 |
110916-44-4 |
95% |
| Y1232916 |
Nickel sulfide (NiS2) |
12035-51-7 |
99% |
| Y1237279 |
HEXAHYDRO-2,6-BIS(2,2,6,6-TETRAMETHYL-4-PIPERIDINYL)-1H,4H,5H,8H-2,3A,4A,6,7A,8A-HEXAAZACYCLOPENTA[DEF]FLUORENE-4,8-DIONE |
109423-00-9 |
98% |
| Y3318390 |
hydroxyachillin |
10180-88-8 |
95% |
| Y1232961 |
oxyphenisatine di(acetate) |
115-33-3 |
98% |